CBDepot introduced the world’s first pharmaceutical GMP natural CBD isolate to the API segment during the world’s biggest pharmaceutical event, the CPhI in Frankfurt, in October 2017.

CBDepot’s work has been constantly driven by innovations. We have been bringing new isolated cannabinoids and new preparations for food and food supplement sectors, which tackle the Novel Food regulation on hemp derivatives in the EU.